Botswana vs Burkina Faso: Protecting minority investors: Ease of shareholder suits index (0-10)
Botswana
30
in 2013
Burkina Faso
30
in 2013
Botswana rank
152nd
Burkina Faso rank
152nd
Protecting minority investors: Ease of shareholder suits index (0-10) over time
- Botswana
- Burkina Faso
How they compare
Botswana currently reports 30 against 30 in Burkina Faso, a difference of 0.
Across all 9 years both countries report, Burkina Faso has been ahead every year.
Botswana ranks 152nd and Burkina Faso ranks 152nd of 191 countries.
Head to head by decade
| Decade | Botswana | Burkina Faso | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30 | 30 | 0 | — |
| 2010s | 30 | 30 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher protecting minority investors: ease of shareholder suits index (0-10), Botswana or Burkina Faso?
- Botswana, at 30 against 30 in Burkina Faso as of 2013.
- What is the difference in protecting minority investors: ease of shareholder suits index (0-10) between Botswana and Burkina Faso?
- 0, with Botswana ahead.
- How many years of comparable data are there for Botswana and Burkina Faso?
- 9 years are reported by both, from 2005 to 2013.
- How do Botswana and Burkina Faso rank globally for protecting minority investors: ease of shareholder suits index (0-10)?
- Botswana ranks 152nd and Burkina Faso ranks 152nd of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Ease of shareholder suits index (0-10) (DB06-14 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for ease of shareholder suits index benchmarks economies with respect to the regulatory best practice on the indicator. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB06-14 studies.